New study: PSMA PET scans may forecast prostate cancer therapy response
NCT ID NCT07089550
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether PSMA PET scans can predict how well advanced prostate cancer patients will respond to treatments like hormone therapy or chemotherapy. Researchers will scan 1300 patients before they start treatment and track their outcomes. The goal is to find imaging markers that help doctors choose the best therapy for each person.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PSMA PET/CT scan (radiation-based imaging)
What this could lead to
If successful, this could help doctors predict which treatments work best for advanced prostate cancer patients, leading to more personalized care.
What could go wrong
This is an observational study, not a treatment trial. It may not change outcomes directly, and results might not apply to all patients or therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Ospedaliera Santa Croce e Carle - ospedale Santa Croce
RECRUITINGCuneo, Italy, 12100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITINGBologna, Italy, 40138, Italy
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
U.O. Medicina Nucleare, IRCCS Ospedale Policlinico San Martino
RECRUITINGGenova, Italy, 16131, Italy
Contact Email: •••••@•••••
Contact Phone: •••-•••-••••
Contact
-
UOC Medicina Nucleare, AOU Policlinico G.Martino
RECRUITINGMessina, Italy, 98125, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact